FDA, COVID and vaccine
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
6hon MSN
The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had formerly been updated annually without complicated trials.